Prader-will Syndrome
📧 Sign up to get email alerts when something new happens for Prader-will Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-08FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Genotropin (somatropin) via a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2016-02-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, Inc., updating/expanding the product’s approv…